• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal Cancer.

作者信息

Sartore-Bianchi Andrea, Marsoni Silvia, Siena Salvatore

机构信息

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Candiolo Cancer Institute-FPO, IRCCS, SP 142 km 3.95, 10060 Candiolo (TO), Italy.

出版信息

JAMA Oncol. 2018 Jan 1;4(1):19-20. doi: 10.1001/jamaoncol.2017.3323.

DOI:10.1001/jamaoncol.2017.3323
PMID:29049531
Abstract
摘要

相似文献

1
Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal Cancer.人表皮生长因子受体2作为转移性结直肠癌的分子生物标志物
JAMA Oncol. 2018 Jan 1;4(1):19-20. doi: 10.1001/jamaoncol.2017.3323.
2
Guidelines for Colorectal Cancer Testing: Evidence-Based Practice Recommendations.
J Mol Diagn. 2017 Mar;19(2):183-186. doi: 10.1016/j.jmoldx.2017.01.002.
3
HER2 testing in metastatic colorectal cancer: ready for prime time?HER2检测在转移性结直肠癌中的应用：准备好进入黄金时代了吗？
Clin Adv Hematol Oncol. 2016 Apr;14(4):235-7.
4
The role of HER2 amplification testing in metastatic colorectal cancer.
Clin Adv Hematol Oncol. 2018 Nov;16(11):720-722.
5
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer.西妥昔单抗耐药的结直肠癌患者循环肿瘤DNA中的HER2基因扩增
Oncotarget. 2016 Jan 19;7(3):3453-60. doi: 10.18632/oncotarget.6498.
6
New Guideline on Managing Colorectal Cancer.新版结直肠癌管理指南
Cancer Discov. 2017 Apr;7(4):OF2. doi: 10.1158/2159-8290.CD-NB2017-030. Epub 2017 Mar 1.
7
Testing for RAS mutations in patients with metastatic colorectal cancer.转移性结直肠癌患者的RAS突变检测
Clin Adv Hematol Oncol. 2014 Jan;12(1):48-9.
8
Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach.分子技术在结直肠癌患者的诊断、预后和管理中的应用：一种实用方法。
Hum Pathol. 2012 Aug;43(8):1157-68. doi: 10.1016/j.humpath.2012.03.003. Epub 2012 Jun 1.
9
CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value.
Adv Cancer Res. 2000;77:169-87. doi: 10.1016/s0065-230x(08)60787-3.
10
Colorectal and gastric cancer in 2015: The development of new agents and molecular classifications.2015年的结直肠癌和胃癌：新型药物及分子分类的进展
Nat Rev Clin Oncol. 2016 Feb;13(2):69-70. doi: 10.1038/nrclinonc.2015.217. Epub 2015 Dec 15.

引用本文的文献

1
A Meta-Analysis to Assess the Efficacy of HER2-Targeted Treatment Regimens in HER2-Positive Metastatic Colorectal Cancer (mCRC).一项旨在评估曲妥珠单抗联合化疗方案在 HER2 阳性转移性结直肠癌（mCRC）患者中的疗效的荟萃分析。
Curr Oncol. 2023 Sep 7;30(9):8266-8277. doi: 10.3390/curroncol30090600.
2
Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies.ERBB2在转移性结直肠癌靶向治疗中的新兴作用：从信号通路到治疗策略
Cancers (Basel). 2022 Oct 21;14(20):5160. doi: 10.3390/cancers14205160.
3
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer.
超越 RAS 和 BRAF：HER2，晚期结直肠癌的新治疗靶点。
Int J Mol Sci. 2021 Jun 24;22(13):6813. doi: 10.3390/ijms22136813.
4
Genetic and biological hallmarks of colorectal cancer.结直肠癌的遗传和生物学特征。
Genes Dev. 2021 Jun;35(11-12):787-820. doi: 10.1101/gad.348226.120.
5
Candidate Molecular Biomarkers for the Non- Invasive Detection of Colorectal Cancer using Gene Expression Profiling.使用基因表达谱进行结直肠癌非侵入性检测的候选分子生物标志物
Iran J Pathol. 2021 Spring;16(2):205-214. doi: 10.30699/IJP.2021.132385.2475. Epub 2021 Mar 2.
6
Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development.我们对转移性结直肠癌（mCRC）肿瘤生物学和遗传学认识的最新进展：聚焦靶向治疗的发展
Onco Targets Ther. 2021 Mar 25;14:2121-2130. doi: 10.2147/OTT.S242224. eCollection 2021.
7
Targeting () Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications.针对晚期或转移性实体瘤患者中经下一代测序鉴定出的超出传统适应症的（）扩增
JCO Precis Oncol. 2019 Oct 21;3. doi: 10.1200/PO.18.00345. eCollection 2019.
8
The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review.通过分子驱动治疗改善原发灶不明癌症（CUP）治疗的探索：一项系统综述
Front Oncol. 2020 May 8;10:533. doi: 10.3389/fonc.2020.00533. eCollection 2020.
9
Precision Medicine in Non Communicable Diseases.非传染性疾病中的精准医学。
Int J Mol Cell Med. 2019 Winter;8(Suppl1):1-18. doi: 10.22088/IJMCM.BUMS.8.2.1. Epub 2019 Jul 25.
10
Contrast enhanced ultrasound imaging by nature-inspired ultrastable echogenic nanobubbles.通过受自然启发的超稳定回声纳米气泡进行对比增强超声成像。
Nanoscale. 2019 Sep 7;11(33):15647-15658. doi: 10.1039/c9nr04828f. Epub 2019 Aug 13.